Results 241 to 250 of about 5,866,745 (304)

Anti‐Carbamylated Protein Antibodies Stabilize Carbamylated Histone H3 to Promote Synovial Activation and Neutrophil Extracellular Trap‐Mediated Bone Loss in Rheumatoid Arthritis

Arthritis &Rheumatology, EarlyView.
Objective Carbamylation, a nonenzymatic post‐translational modification, contributes to rheumatoid arthritis (RA) pathogenesis. Anti‐carbamylated protein antibodies (anti‐CarP) occur in around 50% of patients with RA and associate with greater joint damage. Neutrophil extracellular traps (NETs) are a major source of carbamylated autoantigens. We sought
Shuichiro Nakabo, Norio Hanata, Eduardo Patino‐Martinez, Ronald Holewinski, Ana Barrera‐Vargas, Javier Merayo‐Chalico, Scott A. Coonrod, David A. Fox, Mariana J. Kaplan, Carmelo Carmona‐Rivera   +9 more
wiley   +1 more source

Bacterial Communities as Modulators of Innate Immune Signalling: An In Vitro Perspective on Toll-Like Receptor Activation. [PDF]

Environ Microbiol Rep
Eriksen E, Graff P, Afanou AK.
europepmc   +1 more source

Immune Complexes Shape the Pathogenicity of Autoantibodies in Systemic Autoimmune Diseases: Insights From an FcγRIIIA‐Reporter Assay

Arthritis &Rheumatology, EarlyView.
Objective Immune complexes (ICs), formed by autoantigen and autoantibody, play a pathogenic role in systemic autoimmune diseases through stimulation of Fcγ receptors (FcγR). However, studies investigating bioactivity of circulating ICs across various diseases remain limited.
Koji Suzuki, Masaru Takeshita, Yuki Imai, Hiroyuki Fukui, Kazunori Furuhashi, Kotaro Matsumoto, Jun Kikuchi, Keiko Yoshimoto, Yuko Kaneko   +8 more
wiley   +1 more source

p38 MAP kinase senses short-chain fatty acids to attenuate Toll-like receptor signaling and intestinal inflammation. [PDF]

Sci Adv
Wu Q, Shi R, Xiao L, He X, Chen Z, Zhao H, Liu J, Luo S, Jiang X, Guo D, Meng Y, Zhu R, Li S, Li M, Liu G, Li S, Yang Q, Shen Z, Lu Z.   +18 more
europepmc   +1 more source

IGFL2 suppresses gastric cancer cell sensitivity to docetaxel by activating the Toll-like receptor signaling pathway. [PDF]

iScience
Huang W, Tao Z, Xu X, Cao H, Cheng L, Li J.   +5 more
europepmc   +1 more source

Author Correction: Toll-like receptor 5 on monocyte as a biomarker of mortality risk in patients with sepsis. [PDF]

BMC Infect Dis
Tan H, Wang H, Zhou X, Que W, Yang X.
europepmc   +1 more source

RETRACTION: Glycyrrhizin Attenuates Toll Like Receptor-2, -4 and Experimental Vasospasm in a Rat Model. [PDF]

J Immunol Res
Immunology Research JO.
europepmc   +1 more source

Progression of diabetic nephropathy and adverse renal outcomes: possible involvement of Toll-like receptor 4 expression. [PDF]

Clin Exp Nephrol
Saito A, Abe F, Saito M, Hashimoto M, Kanazawa T, Kumagai T, Sakaguchi M, Ishii F, Nakayama T, Wakui H, Takahashi N.   +10 more
europepmc   +1 more source

Chemerin Activation of Toll-Like Receptor 4 Drives Mineralocorticoid Receptor-Mediated Aortic Valve Remodeling in Chronic Kidney Disease. [PDF]

J Am Heart Assoc
Sánchez-Bayuela T, Soulié M, Garaikoetxea M, Fernández-Celis A, López-Andrés N, Jaisser F.   +5 more
europepmc   +1 more source

[Toll-like receptor and allergy].

Arerugi = [Allergy], 2004
openaire   +2 more sources